[1]
“A STUDY OF LEVELS OF hs-CRP AND LIPID PROFILE IN PATIENTS WITH DIABETIC NEPHROPATHY”, Journal of Pharmaceutical Negative Results, pp. 2163–2174, Oct. 2022, doi: 10.47750/pnr.2022.13.S01.252.